Hubbry Logo
HealingHealingMain
Open search
Healing
Community hub
Healing
logo
8 pages, 0 posts
0 subscribers
Be the first to start a discussion here.
Be the first to start a discussion here.
Healing
Healing
Healing
View on Wikipedia
from Wikipedia
Diagram featuring stages of tissue healing

With physical trauma or disease suffered by an organism, healing involves the repairing of damaged tissue(s), organs and the biological system as a whole and resumption of (normal) functioning. Medicine includes the process by which the cells in the body regenerate and repair to reduce the size of a damaged or necrotic area and replace it with new living tissue. The replacement can happen in two ways: by regeneration in which the necrotic cells are replaced by new cells that form "like" tissue as was originally there; or by repair in which injured tissue is replaced with scar tissue. Most organs will heal using a mixture of both mechanisms.[1]

Within surgery, healing is more often referred to as recovery, and postoperative recovery has historically been viewed simply as restitution of function and readiness for discharge. More recently, it has been described as an energy‐requiring process to decrease physical symptoms, reach a level of emotional well‐being, regain functions, and re‐establish activities[2]

Healing is also referred to in the context of the grieving process.[3]

In psychiatry and psychology, healing is the process by which neuroses and psychoses are resolved to the degree that the client is able to lead a normal or fulfilling existence without being overwhelmed by psychopathological phenomena. This process may involve psychotherapy, pharmaceutical treatment or alternative approaches such as traditional spiritual healing.[citation needed]

Regeneration

[edit]

In order for an injury to be healed by regeneration, the cell type that was destroyed must be able to replicate. Cells also need a collagen framework along which to grow. Alongside most cells there is either a basement membrane or a collagenous network made by fibroblasts that will guide the cells' growth. Since ischaemia and most toxins do not destroy collagen, it will continue to exist even when the cells around it are dead.[citation needed]

Example

[edit]

Acute tubular necrosis (ATN) in the kidney is a case in which cells heal completely by regeneration. ATN occurs when the epithelial cells that line the kidney are destroyed by either a lack of oxygen (such as in hypovolemic shock, when blood supply to the kidneys is dramatically reduced), or by toxins (such as some antibiotics, heavy metals or carbon tetrachloride).[citation needed]

Although many of these epithelial cells are dead, there is typically patchy necrosis, meaning that there are patches of epithelial cells still alive. In addition, the collagen framework of the tubules remains completely intact.[citation needed]

The existing epithelial cells can replicate, and, using the basement membrane as a guide, eventually bring the kidney back to normal. After regeneration is complete, the damage is undetectable, even microscopically.[citation needed]

Healing must happen by repair in the case of injury to cells that are unable to regenerate (e.g. neurons). Also, damage to the collagen network (e.g. by enzymes or physical destruction), or its total collapse (as can happen in an infarct) cause healing to take place by repair Somatic psychology .[citation needed]

Genetics

[edit]

Many genes play a role in healing.[4] For instance, in wound healing, P21 has been found to allow mammals to heal spontaneously. It even allows some mammals (like mice) to heal wounds without scars.[5][6] The LIN28 gene also plays a role in wound healing. It is dormant in most mammals.[7] Also, the proteins MG53 and TGF beta 1 play important roles in wound healing.[8]

Wound healing

[edit]
Main article: Wound healing
See also: Scar free healing
Wounded patients at the Red Cross Hospital in Tampere, Finland during the 1918 Finnish Civil War

In response to an incision or wound, a wound healing cascade is unleashed. This cascade takes place in four phases: clot formation, inflammation, proliferation, and maturation.

Clotting phase

[edit]

Healing of a wound begins with clot formation to stop bleeding and to reduce infection by bacteria, viruses and fungi. Clotting is followed by neutrophil invasion three to 24 hours after the wound has been incurred, with mitoses beginning in epithelial cells after 24 to 48 hours.[citation needed]

Inflammation phase

[edit]

In the inflammatory phase, macrophages and other phagocytic cells kill bacteria, debride damaged tissue and release chemical factors such as growth hormones that encourage fibroblasts, epithelial cells and endothelial cells which make new capillaries to migrate to the area and divide.[citation needed]

Proliferative phase

[edit]

In the proliferative phase, immature granulation tissue containing plump, active fibroblasts forms. Fibroblasts quickly produce abundant type III collagen, which fills the defect left by an open wound. Granulation tissue moves, as a wave, from the border of the injury towards the center.[citation needed]

As granulation tissue matures, the fibroblasts produce less collagen and become more spindly in appearance. They begin to produce the much stronger type I collagen. Some of the fibroblasts mature into myofibroblasts which contain the same type of actin found in smooth muscle, which enables them to contract and reduce the size of the wound.[citation needed]

Maturation phase

[edit]

During the maturation phase of wound healing, unnecessary vessels formed in granulation tissue are removed by apoptosis, and type III collagen is largely replaced by type I. Collagen which was originally disorganized is cross-linked and aligned along tension lines. This phase can last a year or longer. Ultimately a scar made of collagen, containing a small number of fibroblasts is left.[citation needed]

Tissue damaged by inflammation

[edit]

After inflammation has damaged tissue (when combatting bacterial infection for example) and pro-inflammatory eicosanoids have completed their function, healing proceeds in 4 phases.[9]

Recall phase

[edit]

In the recall phase the adrenal glands increase production of cortisol which shuts down eicosanoid production and inflammation.[citation needed]

Resolution phase

[edit]

In the Resolution phase, pathogens and damaged tissue are removed by macrophages (white blood cells). Red blood cells are also removed from the damaged tissue by macrophages. Failure to remove all of the damaged cells and pathogens may retrigger inflammation. The two subsets of macrophage M1 & M2 plays a crucial role in this phase, M1 macrophage being a pro inflammatory while as M2 is a regenerative and the plasticity between the two subsets determine the tissue inflammation or repair.[citation needed]

Regeneration phase

[edit]

In the Regeneration phase, blood vessels are repaired and new cells form in the damaged site similar to the cells that were damaged and removed. Some cells such as neurons and muscle cells (especially in the heart) are slow to recover.[citation needed]

Repair phase

[edit]

In the Repair phase, new tissue is generated which requires a balance of anti-inflammatory and pro-inflammatory eicosanoids. Anti-inflammatory eicosanoids include lipoxins, epi-lipoxins, and resolvins, which cause release of growth hormones.[citation needed]

See also

[edit]

References

[edit]
[edit]
Revisions and contributorsEdit on WikipediaRead on Wikipedia

Healing

View on Grokipedia
from Grokipedia
Healing is the dynamic, multifaceted process by which living organisms repair damage to tissues, recover from illness or , and restore a sense of wholeness across physical, psychological, and spiritual dimensions. In its biological form, particularly , this begins immediately after with a series of overlapping phases: to stop via clot formation, to clear debris through immune cell activity, proliferation to rebuild tissue via and , and remodeling to strengthen the over months or years. These phases involve coordinated cellular, humoral, and molecular interactions, such as platelet activation, recruitment, and signaling, aiming to restore anatomical integrity and function. Disruptions in this process, influenced by factors like , poor , or comorbidities such as , can lead to chronic wounds that persist beyond three months and affect millions globally, imposing significant healthcare burdens. Beyond , healing encompasses a holistic, transformative journey toward transcendence of , where individuals reconcile personal meaning amid distress, fostering repair in mind and spirit even without complete physical . This broader concept, innate to human experience, requires antecedents like acknowledging brokenness and forming connections, yielding consequences such as positive change and . In medical contexts, healing differs from — the latter targets eradication—by emphasizing multidimensional recovery that integrates , emotional support, and environmental factors for optimal outcomes. Advances in , including therapies and bioengineered scaffolds, continue to enhance biological healing as of 2025, while integrative approaches bridge physical and elements to promote comprehensive .

Overview and Types

Definition and Processes

Healing is the by which damaged tissues restore their structure and function following injury, involving coordinated events such as , proliferation, and extracellular matrix (ECM) remodeling. This restoration aims to reinstate tissue integrity and physiological , often through regeneration or scar formation, depending on the extent of damage. The process is dynamic and tightly regulated, integrating cellular signaling, release, and matrix deposition to facilitate recovery without excessive . The earliest documented observations of healing date back to ancient Egyptian papyri, such as the , circa 1600 BCE, which describes wound closure techniques including suturing for traumatic injuries. This text, the oldest known surgical treatise, reflects an empirical understanding of tissue repair through case-based descriptions of trauma management, emphasizing practical interventions to promote closure and prevent complications. In general, biological healing, particularly , unfolds in four overlapping phases: , which stops bleeding through clot formation; , which clears debris via immune responses; proliferation, which rebuilds tissue through , , and epithelialization; and remodeling, which strengthens the repaired tissue over time. These phases ensure progressive repair while minimizing disruption to overall organismal balance. Healing plays a pivotal role in by preventing through rapid barrier restoration, reestablishing protective tissue layers against pathogens, and enabling survival after trauma by mitigating systemic risks like or organ failure. For instance, in , these processes exemplify how timely repair limits microbial invasion and supports vital functions.

Regeneration versus Repair

Regeneration refers to the complete restoration of original tissue architecture and function following , often achieved through processes such as of mature cells into -like states and the formation of a —a mass of undifferentiated, proliferating cells that directs patterned regrowth. This mode of healing requires the activation of stem or cells to rebuild complex structures without significant scarring, as seen in certain and models where the regenerated tissue matches the pre- state in both form and functionality. In contrast, repair involves partial restoration of tissue integrity when regenerative capacity is limited, primarily through , where fibroblasts proliferate and deposit excessive components like , leading to formation. This process prioritizes rapid wound closure over architectural fidelity, resulting in a fibrotic mass that may compromise long-term tissue elasticity and function. The key differences between regeneration and repair lie in their outcomes: regenerative healing preserves full organ function and avoids scarring, exemplified by the regrowth of liver lobules in mammals, where hepatocytes proliferate to restore the precise hepatic architecture without , maintaining metabolic capacity. Repair, however, often leads to contractures or reduced elasticity, as in adult wounds where collagen-rich scars form, impairing flexibility and potentially hindering movement. Evolutionarily, regenerative capacity is more pronounced in invertebrates, such as planarian flatworms, which can regenerate an entire body from small fragments through the action of pluripotent neoblast stem cells that repopulate all tissues via formation and morphallaxis. In vertebrates, this ability diminishes phylogenetically, with mammals exhibiting limited regeneration compared to amphibians like salamanders, which employ epimorphic processes to fully regenerate limbs through , development, and precise patterning that recreates skeletal, muscular, and neural elements. Factors influencing whether healing proceeds via regeneration or repair include injury size, with larger wounds favoring fibrotic repair due to heightened inflammatory responses; tissue type, as labile tissues like regenerate more readily than permanent ones like ; age, where fetal or juvenile stages support regeneration through reduced ; and species differences, underscoring the evolutionary trade-offs in healing strategies. Genetic factors, such as the expression of specific transcription regulators, can enable regeneration in model organisms by promoting and stem cell mobilization.

Molecular and Cellular Foundations

Genetic Regulation

The genetic regulation of healing encompasses the orchestration of that coordinates cellular responses to , ensuring coordinated repair and regeneration across tissues. Key signaling pathways and transcription factors act as molecular blueprints, modulating proliferation, differentiation, and deposition without directly executing cellular migration. These mechanisms are tightly controlled to balance repair and prevent pathological outcomes like excessive scarring. Central to this regulation are core genes from the transforming growth factor-β (TGF-β) family, such as TGF-β1, which promotes by stimulating production and activation during the repair process. growth factors (FGFs), including FGF2 and FGF7, drive and essential for tissue rebuilding. The Wnt/β-catenin pathway further maintains populations by stabilizing β-catenin to activate target genes involved in self-renewal and regenerative competence. Epigenetic modifications fine-tune across healing phases, with silencing pro-inflammatory genes to facilitate resolution, while enhances accessibility of repair-related loci like those encoding matrix proteins. These dynamic changes, such as increased H3K27 during proliferation, allow rapid adaptation to injury without altering the underlying DNA sequence. Genetic disorders highlight the fragility of these pathways; in Ehlers-Danlos syndrome, mutations in genes like COL5A1 impair fibril assembly, resulting in wounds with reduced tensile strength and delayed closure. Conversely, keloid formation arises from TGF-β overexpression, which hyperactivates fibroblasts and leads to excessive accumulation beyond normal repair boundaries. From an evolutionary perspective, in regenerative species like the encode positional memory, enabling precise limb regrowth by maintaining anterior-posterior identities through feedback loops involving HoxA13 and Shh signaling. This contrasts with mammals, where attenuated Hox expression limits regeneration to scarring. Recent advances include CRISPR-Cas9 editing of the gene in mesenchymal stem cells, which suppresses and boosts proliferative capacity, thereby enhancing overall regenerative potential in tissue repair models.

Cellular Components

Healing at the cellular level relies on a coordinated orchestra of specialized cell types that execute the repair process through migration, proliferation, , and programmed . These cells form the machinery that translates molecular signals into tissue restoration, with primary effectors including platelets, immune cells like neutrophils and macrophages, stromal cells such as fibroblasts, and epithelial and vascular cells like and endothelial cells. Platelets are among the first responders, aggregating at injury sites to form a fibrin clot that stabilizes the and releases growth factors such as (PDGF) and transforming growth factor-beta (TGF-β), which initiate and recruit subsequent cells. Neutrophils arrive rapidly within hours, performing to clear pathogens and debris while releasing (ROS) and ; their numbers peak early but typically decline through to prevent prolonged . Macrophages, derived from circulating monocytes, follow and dominate the , shifting from a pro-inflammatory M1 phenotype—characterized by of tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6)—to an M2 phenotype that promotes resolution via IL-10 and (VEGF). Fibroblasts then proliferate to synthesize (ECM) components like types III and I, differentiating into contractile myofibroblasts that facilitate closure. Keratinocytes migrate from edges to re-epithelialize the surface, guided by (EGF) and keratinocyte growth factor (KGF), while endothelial cells sprout new vessels through , driven by VEGF and basic fibroblast growth factor (bFGF), to restore . Stem cells, particularly mesenchymal stem cells (MSCs) from or , play supportive roles by differentiating into repair-competent lineages and exerting paracrine effects through exosomes that deliver growth factors and modulate , enhancing overall tissue regeneration without directly replacing lost cells. Cell-cell interactions are predominantly mediated by cytokines and ; for instance, IL-1 released by macrophages activates fibroblasts to boost ECM production, while TNF-α from neutrophils coordinates endothelial cell recruitment for vascularization. Cellular dynamics ensure timely progression, with regulating cell populations—neutrophils self-eliminate after 24-48 hours to curb , and myofibroblasts undergo programmed death post-contraction to avoid . The M1-to- polarization of macrophages exemplifies this balance, triggered by environmental cues like interferon-gamma (IFN-γ) for M1 activation and IL-4 for resolution, preventing excessive tissue damage. In pathological conditions, such as chronic wounds, dysregulation manifests as persistent neutrophils that resist and form (NETs), leading to excessive release that degrades ECM and perpetuates , often compounded by stalled polarization and reduced MSC .

Wound Healing

Hemostasis Phase

The hemostasis phase initiates immediately following tissue injury, serving as the foundational step in by rapidly stabilizing the wound site to prevent excessive blood loss. This process begins with vascular , where damaged endothelial cells and surrounding trigger the contraction of blood vessels, reducing blood flow to the injury site within seconds to minutes. Concurrently, exposed subendothelial activates circulating platelets, leading to their and aggregation, which forms a temporary to seal the breach. Central to this phase is the activation of the coagulation cascade, a series of enzymatic reactions that culminate in the conversion of soluble fibrinogen into insoluble strands, creating a stable clot. The cascade operates through two primary pathways: the extrinsic pathway, initiated by exposure from damaged cells, and the intrinsic pathway, triggered by contact activation on negatively charged surfaces; both converge on the activation of , leading to the generation of (factor IIa). then cleaves fibrinogen to form fibrin monomers, which polymerize into a that reinforces the , trapping red blood cells and additional platelets to form a definitive hemostatic clot. This network acts as a provisional matrix, providing for subsequent healing phases. Platelets play a multifaceted role beyond plug formation, as their releases alpha granules containing key growth factors such as (PDGF) and (VEGF), which initiate to recruit and activate cells involved in repair. These factors promote endothelial and early , setting the stage for tissue regeneration. The phase typically lasts from 30 minutes to a few hours, though it can extend up to several hours depending on wound severity, after which the clot provides a temporary for migrating cells. In clinical contexts, particularly surgical healing, anticoagulant therapies like can impair this phase by enhancing III activity, thereby inhibiting and factor Xa, which may prolong and necessitate careful perioperative management to balance risk with hemostatic integrity. As the clot stabilizes, platelet-derived cytokines begin to signal the transition to the inflammatory phase, attracting immune cells to the site.

Inflammatory Phase

The inflammatory phase of , occurring approximately 2–3 days post-injury, is dominated by innate immune activation to clear debris and pathogens, setting the stage for subsequent tissue repair. This phase begins shortly after , with increased facilitating the influx of immune cells to the site, thereby limiting further damage and initiating . Key events involve an initial surge of neutrophils, the first responders, which migrate to the injury within hours and perform to engulf , dead cells, and foreign material, effectively decontaminating the bed. Following neutrophils, monocytes from the bloodstream differentiate into macrophages, which sustain the cleanup process through prolonged and orchestrate the transition to later healing stages by modulating the local environment. These macrophages play a pivotal role in bridging to proliferation, though experimental models indicate that neutrophil depletion does not always halt healing, underscoring the phase's redundancy in acute responses. Chemotaxis drives immune cell recruitment, primarily through chemokines such as CXCL8 (also known as IL-8), which attracts neutrophils and amplifies the response. Pro-inflammatory cytokines released by these cells, including TNF-α and IL-6, further intensify the inflammatory milieu by promoting additional leukocyte infiltration and antimicrobial activity. Neutrophils and early macrophages contribute to this by secreting TNF-α, IL-6, and CXCL8, enhancing defense but also generating that must be tightly regulated. Resolution of the inflammatory phase occurs via a phenotypic shift in macrophages toward an state, marked by the production of mediators like IL-10, which dampens pro-inflammatory signals to prevent tissue overdamage and chronicity. Dysregulation, such as excessive or prolonged , can delay healing; for instance, in diabetic ulcers, systemic factors like hypoxia elevate pro-inflammatory cytokines (e.g., TNF-α) and matrix metalloproteinases, leading to persistent , impaired debris clearance, and non-healing wounds.

Proliferative Phase

The proliferative phase of , also known as the reconstructive or fibroblastic phase, typically spans from day 4 to day 21 post-injury and marks the transition to active tissue rebuilding following inflammation resolution. This phase involves the migration of fibroblasts into the wound site, where they proliferate and begin synthesizing new (ECM) components to replace the provisional clot. The onset is triggered by reparative signals from macrophages shifting to an M2 , promoting release that initiates these constructive processes. A central feature is the formation of granulation tissue, a highly vascularized and cellular matrix composed primarily of type III collagen produced by fibroblasts, along with new capillaries, proteoglycans, and . This pink, granular-appearing tissue fills the bed, providing a scaffold for further repair; type III collagen predominates initially due to its flexibility, supporting rapid tissue deposition before later remodeling to the stronger . Fibroblasts, activated by cytokines such as transforming growth factor-beta (TGF-β), drive ECM synthesis, ensuring structural integrity during this rebuilding stage. Angiogenesis is a key process, stimulated by hypoxia-induced (VEGF) secreted from macrophages, , and , leading to the sprouting of new blood vessels from existing capillaries to supply oxygen and nutrients to the healing site. Concurrently, re-epithelialization occurs as from the wound edges and adnexal structures migrate across the surface, restoring the epidermal barrier through proliferation and differentiation guided by (EGF). (PDGF) further enhances and proliferation, coordinating these cellular activities for efficient coverage. Wound contraction, mediated by myofibroblasts—specialized fibroblasts expressing alpha-smooth muscle actin—pulls the wound edges together via actin-mediated tension on fibers, significantly reducing the wound area, often by up to 80% in open wounds. This process, peaking around days 10-14, minimizes the volume of tissue needed for repair and is regulated by mechanical cues and growth factors like TGF-β.

Maturation Phase

The maturation phase of wound healing, also known as the remodeling phase, begins approximately 21 days after and can extend from weeks to years, during which the provisional (ECM) is reorganized into a more stable structure. Collagen fibers undergo cross-linking and realignment along lines of mechanical stress, gradually increasing the tensile strength of the healed tissue to about 80% of the uninjured skin's strength. This process involves the of excess fibroblasts, myofibroblasts, and endothelial cells that were recruited during earlier phases, reducing cellularity and vascularity to form a mature . ECM remodeling is primarily mediated by matrix metalloproteinases (MMPs), such as MMP-1 and MMP-13, which degrade disorganized , while their inhibitors, tissue inhibitors of metalloproteinases (TIMPs), like TIMP-1 and TIMP-3, regulate this activity to prevent excessive breakdown and ensure balanced deposition of . During scar evolution, the initially red, vascular, and immature scar transitions to a pale, white, and avascular mature form as blood vessels regress and collagen bundles reorganize, typically over several months to years. In predisposed individuals, such as those with darker tones or younger age, this phase may lead to hypertrophic scarring, characterized by excessive deposition and raised, thickened tissue confined to the original boundaries. Biomechanically, tensile strength in the maturing scar is quantified as stress (force per unit area), calculated as σ=FA\sigma = \frac{F}{A}, where σ\sigma is stress, FF is applied force, and AA is cross-sectional area; healed tissue ultimately achieves 70-80% of the original uninjured strength due to optimized cross-linking. Nutritional factors, particularly , are crucial for efficient remodeling, as it serves as a cofactor for prolyl and lysyl hydroxylases, enabling proper and cross-linking stability. Advanced age impairs remodeling efficiency by reducing proliferation, diminishing ECM deposition, and enhancing MMP activity, leading to weaker scars and prolonged healing times.

Inflammation-Induced Tissue Response

Trained Immunity and Resolution

In contexts of inflammation-induced tissue response, particularly in non-wound scenarios such as autoimmune or chronic conditions, tissues can exhibit innate immune memory—known as trained immunity—through epigenetic reprogramming of innate immune cells in response to prior exposures. This memory enables enhanced responses upon re-exposure, including rapid recognition of via receptors (PRRs), such as Toll-like receptors (TLRs), which detect damage-associated molecular patterns (DAMPs) released from stressed or dying cells. DAMPs, including high-mobility group box 1 () and heat shock proteins, signal tissue and trigger innate immune activation. The resolution phase actively terminates inflammation to prevent escalation, primarily through specialized pro-resolving mediators (SPMs) derived from omega-3 fatty acids, such as resolvins and protectins. These lipid mediators, biosynthesized by enzymes like 15-lipoxygenase, promote —the non-phlogistic of apoptotic neutrophils and other cells by macrophages—thereby clearing inflammatory debris and restoring tissue . Resolvins, for instance, interact with G-protein-coupled receptors (e.g., GPR32 and ALX/FPR2) to dampen production and enhance microbial clearance without . This process from trained immunity activation to resolution unfolds over hours to days following inflammatory onset, ensuring timely dampening to avert chronicity; unresolved inflammation beyond this window can lead to persistent tissue damage in conditions like . Key cellular players include , which produce pro-resolving mediators like protectin D1 to facilitate apoptosis and , and regulatory T-cells (Tregs), which suppress excessive effector responses and promote polarization toward an M2 . As of 2025, clinical advancements include the completion of a Phase 1a trial for an oral resolvin E1 analog (TP-317), demonstrating safety and preliminary efficacy in promoting mucosal healing in inflammatory bowel disease by activating BLT1 receptors to enhance resolution pathways. These analogs target the resolution phase to address unmet needs in chronic inflammatory disorders, building on preclinical evidence of reduced disease severity.

Regeneration and Repair Outcomes

In inflammation-damaged tissues, the resolution of the inflammatory response early in the process can lead to regeneration, characterized by full tissue reconstitution through the proliferation of resident cells. For instance, in the liver following acute , proliferation restores normal architecture without scarring if inflammation subsides promptly. Conversely, prolonged shifts the outcome toward repair, resulting in fibrotic scarring that replaces functional tissue with deposits, as seen in developing after severe . The balance between regenerative and reparative outcomes is modulated by competing signaling pathways, where pro-regenerative factors such as bone morphogenetic proteins (BMPs) promote tissue rebuilding, while pro-fibrotic signals like transforming growth factor-β (TGF-β) drive excessive matrix production and activation. BMP7, in particular, counteracts TGF-β's fibrotic effects by inhibiting Smad3 nuclear accumulation in mesenchymal cells, thereby favoring regeneration over . Outcomes are assessed using histological markers, with persistent expression of alpha-smooth muscle actin (α-SMA) indicating differentiation and ongoing risk, as opposed to transient expression in regenerative scenarios. Therapeutic strategies targeting this repair bias include anti-fibrotic drugs like , which inhibits TGF-β-driven activation and synthesis to prevent excessive scarring in inflammatory contexts.

Tissue-Specific Healing

Bone and Cartilage

Bone healing primarily occurs through two distinct mechanisms: , where bone forms directly from mesenchymal cells without a intermediate, and , which involves a cartilaginous template that is later replaced by bone. is characteristic of stable fractures or primary under rigid fixation, while predominates in secondary healing of unstable fractures, mirroring embryonic bone development. These processes ensure the restoration of skeletal integrity, adapting to the mechanical environment of the injury site. The healing process unfolds in sequential stages. Initially, hematoma formation occurs immediately after fracture, providing a fibrin scaffold for inflammatory cell recruitment and vascular invasion. This transitions to the soft callus stage, where fibroblasts and chondroblasts produce a cartilaginous matrix through endochondral ossification, stabilizing the fracture site within 2-3 weeks. The hard callus phase follows, with endochondral ossification converting the cartilage to woven bone via osteoblast activity, typically over 3-4 weeks. Finally, remodeling refines the bone structure, replacing woven bone with lamellar bone through coordinated osteoclastic resorption and osteoblastic deposition, which can persist for months to years. Key cellular players include osteoblasts, which synthesize matrix and secrete to facilitate mineralization by hydrolyzing inhibitors, and osteoclasts, which resorb damaged via acid secretion and proteolytic enzymes to prepare sites for new formation. These cells act in balanced units during remodeling, ensuring structural adaptation. In cartilage, healing is constrained by its avascular nature, limiting nutrient diffusion and cellular proliferation; defects often repair with mechanically inferior rather than native . Mechanical loading influences healing per , whereby bone architecture remodels to optimize strength against applied stresses, promoting formation under controlled motion but risking delayed union with excessive or insufficient load. delays this process due to reduced and impaired cellular recruitment, increasing non-union risks. Clinically, uncomplicated fractures heal in 6-8 weeks, but non-unions—occurring in up to 10% of cases—affect about 5-10% of fractures and are treated with recombinant human bone morphogenetic protein-2 () grafts to stimulate osteogenesis, achieving union rates over 80%.

Soft Tissues and Organs

Healing in soft tissues and organs involves distinct mechanisms tailored to their cellular composition and functional demands, often balancing regeneration with repair to restore tissue integrity without compromising organ performance. Unlike rigid structures, these tissues rely on cellular proliferation, remodeling, and vascular support to overcome injury, though outcomes vary by organ regenerative capacity. In , repair begins with the activation of satellite cells, quiescent stem cells located beneath the of muscle fibers, which proliferate and differentiate to fuse with damaged fibers or form new myofibers, enabling regeneration after minor injuries. In severe tears or chronic damage, however, excessive deposition leads to , replacing functional muscle with and impairing contractility. The liver exhibits remarkable regenerative potential through compensatory , where following partial —such as removal of up to 70% of the organ—hepatocytes enter the with peak around 7-14 days, restoring mass within approximately 3 months in humans or 7-10 days in models via proliferation of remaining mature hepatocytes. Peripheral healing initiates with , an anterograde process where the distal segment fragments and is cleared by macrophages and Schwann cells, followed by axonal regrowth from the proximal stump at a rate of approximately 1 mm per day, guided by proliferating Schwann cells that form bands of Büngner to direct regeneration and remyelinate axons. A key barrier to healing in organs is vascular supply, as ischemia—reduced blood flow—impairs nutrient delivery and oxygen availability, delaying recovery; for instance, in the , ischemia-reperfusion injury post-transplantation prolongs graft dysfunction by triggering and tubular damage. Recent advances in 2025 include therapies for post-myocardial , where infusions have demonstrated improvements in left ventricular by 4-5% at 6 months in meta-analyses of clinical trials, enhancing systolic function through paracrine effects and reduced scarring.

References

  1. https://www.ncbi.nlm.nih.gov/books/NBK535406/
  2. https://pmc.ncbi.nlm.nih.gov/articles/PMC4653605/
  3. https://www.liebertpub.com/doi/10.1089/wound.2023.0150
  4. https://pmc.ncbi.nlm.nih.gov/articles/PMC2903966/
  5. https://pmc.ncbi.nlm.nih.gov/articles/PMC8432991/
  6. https://pubmed.ncbi.nlm.nih.gov/41075105/
  7. https://pmc.ncbi.nlm.nih.gov/articles/PMC5087220/
  8. https://medicine.nus.edu.sg/pathweb/pathology-demystified/healing-and-repair/
  9. https://pmc.ncbi.nlm.nih.gov/articles/PMC3055648/
  10. https://www.bmj.com/content/342/bmj.d1598
  11. https://pmc.ncbi.nlm.nih.gov/articles/PMC2989268/
  12. https://pmc.ncbi.nlm.nih.gov/articles/PMC7950476/
  13. https://www.nature.com/articles/nature07039
  14. https://pmc.ncbi.nlm.nih.gov/articles/PMC4973620/
  15. https://pubmed.ncbi.nlm.nih.gov/32764740/
  16. https://pmc.ncbi.nlm.nih.gov/articles/PMC7706840/
  17. https://www.ncbi.nlm.nih.gov/books/NBK9971/
  18. https://pmc.ncbi.nlm.nih.gov/articles/PMC3857353/
  19. https://journals.biologists.com/dev/article/144/22/4047/48212/Fibroblast-growth-factors-key-players-in
  20. https://www.nature.com/articles/s41392-021-00762-6
  21. https://pmc.ncbi.nlm.nih.gov/articles/PMC4085819/
  22. https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-020-02303-1
  23. https://pmc.ncbi.nlm.nih.gov/articles/PMC4849881/
  24. https://www.nature.com/articles/srep32231
  25. https://www.nature.com/articles/s41586-025-09036-5
  26. https://pmc.ncbi.nlm.nih.gov/articles/PMC12004386/
  27. https://pmc.ncbi.nlm.nih.gov/articles/PMC7536089/
  28. https://pmc.ncbi.nlm.nih.gov/articles/PMC6442927/
  29. https://pmc.ncbi.nlm.nih.gov/articles/PMC10525842/
  30. https://www.ncbi.nlm.nih.gov/books/NBK470443/
  31. https://www.ncbi.nlm.nih.gov/books/NBK482253/
  32. https://pmc.ncbi.nlm.nih.gov/articles/PMC4452143/
  33. https://www.frontiersin.org/journals/bioengineering-and-biotechnology/articles/10.3389/fbioe.2021.716184/full
  34. https://pmc.ncbi.nlm.nih.gov/articles/PMC4508384/
  35. https://pmc.ncbi.nlm.nih.gov/articles/PMC8150999/
  36. https://pmc.ncbi.nlm.nih.gov/articles/PMC5021733/
  37. https://pmc.ncbi.nlm.nih.gov/articles/PMC6582859/
  38. https://www.ncbi.nlm.nih.gov/books/NBK554402/
  39. https://pmc.ncbi.nlm.nih.gov/articles/PMC5094847/
  40. https://emedicine.medscape.com/article/884594-overview
  41. https://www.ncbi.nlm.nih.gov/books/NBK534261/
  42. https://www.hmpgloballearningnetwork.com/site/wounds/article/1746
  43. https://www.liebertpub.com/doi/10.1089/wound.2014.0581
  44. https://pmc.ncbi.nlm.nih.gov/articles/PMC9360851/
  45. https://www.sciencedirect.com/topics/immunology-and-microbiology/scar-formation
  46. https://pmc.ncbi.nlm.nih.gov/articles/PMC10000648/
  47. https://www.xometry.com/resources/materials/ultimate-tensile-strength/
  48. https://www.physio-pedia.com/Wound_Healing
  49. https://pubmed.ncbi.nlm.nih.gov/1720597/
  50. https://www.sciencedirect.com/science/article/pii/S0022202X20323605
  51. https://journals.cambridgemedia.com.au/wpr/volume-28-number-3/what-effect-age-wound-healing-acute-trauma-setting-scoping-review
  52. https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2021.699563/full
  53. https://www.sciencedirect.com/science/article/pii/S1074761324000980
  54. https://pmc.ncbi.nlm.nih.gov/articles/PMC6117512/
  55. https://www.nature.com/articles/nri.2015.4
  56. https://www.sciencedirect.com/science/article/pii/S155041311300418X
  57. https://www.jci.org/articles/view/97943
  58. https://www.sciencedirect.com/topics/engineering/inflammatory-phase
  59. https://pmc.ncbi.nlm.nih.gov/articles/PMC8558534/
  60. https://rupress.org/jem/article/202/11/1539/52651/Resolution-of-airway-inflammation-and
  61. https://www.researchgate.net/publication/388312220_P0627_Pharmacokinetics_Pharmacodynamics_Safety_and_Efficacy_of_Oral_Resolvin_E1-based_Therapy_in_Inflammatory_Bowel_Disease_IBD_Translating_Resolvin_E1_Activation_of_BLT1_in_Experimental_Models_to_Hea
  62. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0049611
  63. https://pmc.ncbi.nlm.nih.gov/articles/PMC9735580/
  64. https://pmc.ncbi.nlm.nih.gov/articles/PMC6829314/
  65. https://pmc.ncbi.nlm.nih.gov/articles/PMC4471834/
  66. https://pmc.ncbi.nlm.nih.gov/articles/PMC9530045/
  67. https://www.ncbi.nlm.nih.gov/books/NBK551678/
  68. https://www.nature.com/articles/s41598-018-22095-1
  69. https://www.orthobullets.com/basic-science/9009/fracture-healing
  70. https://pubmed.ncbi.nlm.nih.gov/32522695/
  71. https://my.clevelandclinic.org/health/body/24871-osteoblasts-and-osteoclasts
  72. https://www.frontiersin.org/journals/bioengineering-and-biotechnology/articles/10.3389/fbioe.2021.770655/full
  73. https://pmc.ncbi.nlm.nih.gov/articles/PMC8719005/
  74. https://pubmed.ncbi.nlm.nih.gov/8060014/
  75. https://pmc.ncbi.nlm.nih.gov/articles/PMC8379440/
  76. https://pmc.ncbi.nlm.nih.gov/articles/PMC8509770/
  77. https://pmc.ncbi.nlm.nih.gov/articles/PMC8533525/
  78. https://pmc.ncbi.nlm.nih.gov/articles/PMC3156644/
  79. https://pmc.ncbi.nlm.nih.gov/articles/PMC5292184/
  80. https://pmc.ncbi.nlm.nih.gov/articles/PMC7665117/
  81. https://www.sciencedirect.com/science/article/pii/S0753332224005298
  82. https://www.frontiersin.org/journals/molecular-neuroscience/articles/10.3389/fnmol.2020.608442/full
  83. https://pmc.ncbi.nlm.nih.gov/articles/PMC11050495/
  84. https://www.mdpi.com/2077-0383/9/1/253
  85. https://pmc.ncbi.nlm.nih.gov/articles/PMC11389242/
Add your contribution
Related Hubs
User Avatar
No comments yet.